Inhibition of miR-25 improves cardiac contractility in the failing heart

Nature

Volumn 508, Issue 7497, 2014, Pages 531-535

  Wahlquist, Christine ^a   Jeong, Dongtak ^b   Rojas Muñoz, Agustin ^a   Kho, Changwon ^b   Lee, Ahyoung ^b   Mitsuyama, Shinichi ^b   Van Mil, Alain ^a,c   Jin Park, Woo ^d   Sluijter, Joost P G ^c   Doevendans, Pieter A F ^c   Hajjar, Roger J ^b   Mercola, Mark ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; MICRORNA; MICRORNA 25; OLIGONUCLEOTIDE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; CELL ORGANELLE; DATA SET; GENE EXPRESSION; INHIBITION; MUSCLE; RODENT; VIRUS;

ADENO ASSOCIATED VIRUS; ADULT; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; UPREGULATION;

ANIMALS; CALCIUM; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; HEART; HEART FAILURE; HEK293 CELLS; HUMANS; KINETICS; MALE; MICE; MICRORNAS; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 84899482237     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13073     Document Type: Article

References (44)

1. Bonow, R. O., Mann, D. L., Zipes, D. P. & Libby, P. Braunwald's Heart Disease (Saunders, 2011).
2. Meyer, M. et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92, 778-784 (1995).
3. Jessup, M. et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): aphase2trial of intracoronary genetherapy of sarcoplasmic reticulum Ca21-ATPase in patients with advanced heart failure. Circulation 124, 304-313 (2011).
4. Ikeda, S. et al. Altered microRNA expression in human heart disease. Physiol. Genomics 31, 367-373 (2007).
5. Leptidis, S. et al. A deep sequencing approach to uncover the miRNOME in the human heart. PLoS ONE 8, e57800 (2013).
6. Shah, A. M. & Mann, D. L. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 378, 704-712 (2011).
7. Mudd, J. O. & Kass, D. A. Tackling heart failure in the twenty-first century. Nature 451, 919-928 (2008).
8. Greenstein, J. L. & Winslow, R. L. Integrative systems models of cardiac excitation-contraction coupling. Circ. Res. 108, 70-84 (2011).
9. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
10. Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nature Rev. Genet. 9, 102-114 (2008).
11. Gurha, P. et al. Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 125, 2751-2761 (2012).
12. Kawase, Y. et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J. Am. Coll. Cardiol. 51, 1112-1119 (2008).
13. Shirdel, E. A., Xie, W., Mak, T. W. & Jurisica, I. NAViGaTing the micronome-using multiple microRNA prediction databases to identify signalling pathwayassociated microRNAs. PLoS ONE 6, e17429 (2011).
14. Lemons, D., Maurya, M. R., Subramaniam, S. & Mercola, M. Developing microRNA screening as a functional genomics tool for disease research. Front. Physiol. 4, 223 (2013).
15. Cerignoli, F. et al. High throughput measurement of Ca21 dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry. J. Pharmacol. Toxicol. Methods 66, 246-256 (2012).
16. Beuckelmann, D. J., Nabauer, M. & Erdmann, E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85, 1046-1055 (1992).
17. Piacentino, V. III et al. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ. Res. 92, 651-658 (2003).
18. Krü tzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005).
19. Bonauer, A. et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324, 1710-1713 (2009).
20. Helwak, A., Kudla, G., Dudnakova, T. & Tollervey, D. Mapping the human miRNA interactome by CLASHreveals frequent noncanonical binding. Cell 153, 654-665 (2013).
21. Kho, C. et al. SUMO1-dependent modulation of SERCA2a in heart failure. Nature 477, 601-605 (2011).
22. Kho, C., Lee, A. & Hajjar, R. J. Altered sarcoplasmic reticulum calcium cycling-targets for heart failure therapy. Nature Rev. Cardiol. 9, 717-733 (2012).
23. Higazi, D. R. et al. Endothelin-1-stimulated InsP3-induced Ca21 release is a nexus for hypertrophic signaling in cardiac myocytes. Mol. Cell 33, 472-482 (2009).
24. Hulot, J. S. et al. Critical role for stromal interaction molecule 1 in cardiac hypertrophy. Circulation 124, 796-805 (2011).
25. Fu, Y. et al. Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy.Am. J. Nephrol. 32, 581-589 (2010).
26. Schmidt, H. H., Wingler, K., Kleinschnitz, C. & Dusting, G. NOX4 is a Janus-faced reactive oxygen species generating NADPH oxidase. Circ. Res. 111, e15-16 (2012).
27. Dirkx, E. et al. Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nature Cell Biol. 15, 1282-1293 (2013).
28. Colas, A. R. et al.Whole-genome microRNAscreening identifies let-7 andmir-18as regulators of germ layer formation during early embryogenesis. Genes Dev. 26, 2567-2579 (2012).
29. McKeithan, W. L., Colas, A. R., Bushway, P. J., Ray, S. & Mercola, M. Serum-free generation ofmultipotent mesoderm(Kdr1) progenitor cells in mouse embryonic stem cells for functional genomics screening. Curr. Protoc. Stem Cell Biol. Chapter 1, 13 (2012).
30. Roy, S. et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 82, 21-29 (2009).
31. Matkovich, S. J. et al. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 119, 1263-1271 (2009).
32. van Rooij, E. et al. Dysregulation of microRNAs aftermyocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl Acad. Sci. USA 105, 13027-13032 (2008).
33. Cheng, Y. et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am. J. Pathol. 170, 1831-1840 (2007).
34. Tatsuguchi, M. et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 42, 1137-1141 (2007).
35. Sayed, D., Hong, C., Chen, I. Y., Lypowy, J. & Abdellatif, M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res. 100, 416-424 (2007).
36. van Rooij, E. et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl Acad. Sci. USA 103, 18255-18260 (2006).
37. Zolotukhin, S. et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973-985 (1999).
38. Andersson, K. B. et al. Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J. Mol. Cell. Cardiol. 47, 180-187 (2009).
39. Swift, F. et al. Extreme sarcoplasmic reticulum volume loss and compensatory T-tubule remodeling after Serca2 knockout. Proc. Natl Acad. Sci. USA 109, 3997-4001 (2012).
40. Pacher, P., Nagayama, T.,Mukhopadhyay, P., Batkai, S. & Kass, D. A. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nature Protocols 3, 1422-1434 (2008).
41. Bers, D. M. Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 70, 23-49 (2008).
42. Kockskämper, J. et al. Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes. J. Mol. Cell. Cardiol. 45, 128-147 (2008).
43. Bootman, M. D. & Roderick, H. L. Why, where, and when do cardiac myocytes express inositol 1,4,5-trisphosphate receptors? Am. J. Physiol. Heart Circ. Physiol. 294, H579-H581 (2008).
44. Zima, A. V., Bare, D. J., Mignery, G. A. & Blatter, L. A. IP3-dependent nuclear Ca21 signalling in the mammalian heart. J. Physiol. (Lond.) 584, 601-611 (2007).